Literature DB >> 11244260

Characteristics and evolution of extraintestinal manifestations associated with ulcerative colitis after proctocolectomy.

P Goudet1, R R Dozois, K A Kelly, D M Ilstrup, S F Phillips.   

Abstract

AIMS: Describe the characteristics of extraintestinal manifestations complicating ulcerative colitis present preoperatively and determine their evolution after surgery.
METHODS: Between 1976 and 1986, 281 patients with ulcerative colitis exhibiting one or more extraintestinal manifestations (EIM) before either IPAA (n = 147), Brooke ileostomy (n = 71), Kock pouch (n = 48) or ileorectostomy (n = 15) were assessed retrospectively. The clinical evolution of each manifestation was classified as having disappeared, improved, remained unchanged or aggravated postoperatively. An efficacy index was designed to assess the ratio of the number of cases cured or improved over the number of cases unchanged or aggravated. The relationship between EIM and gender, age, duration of disease and the type of surgery was also ascertained.
RESULTS: 433 EIM were observed in 281 patients. The most common were arthralgias of the large joints (n = 146), of the sacroiliac joint (n = 59) and the small joints (n = 51). In comparison to patients without EIM having received the same operation during the same period of time, EIM were seen more often in women, younger patients, than those with longer duration of disease and the ileoanal anastomosis group. 60% had only one EIM at a time. Based on the efficacy index, thromboembolic accidents and erythema nodosum were the most commonly cured or improved. Ocular manifestations and primary sclerosing cholangitis were unaffected. The other EIM responded favorably but variably with improvement in two thirds of patients. The presence of a rectal remnant (IRA) or ileal reservoir did not affect the evolution of the EIM.
CONCLUSIONS: Thromboembolic complications which are life-threatening, erythema nodosum and arthralgia of the small and large joints which impair quality of life, benefited the most from proctocolectomy. Those conditions may be considered preoperatively when making the decision for surgery.

Entities:  

Mesh:

Year:  2001        PMID: 11244260     DOI: 10.1159/000050097

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  14 in total

Review 1.  Extraintestinal manifestations in inflammatory bowel disease.

Authors:  Silvio Danese; Stefano Semeraro; Alfredo Papa; Italia Roberto; Franco Scaldaferri; Giuseppe Fedeli; Giovanni Gasbarrini; Antonio Gasbarrini
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

2.  Technical aspects of ileoanal pouch surgery.

Authors:  Peter W G Carne; John H Pemberton
Journal:  Clin Colon Rectal Surg       Date:  2004-02

Review 3.  Surgery for inflammatory bowel disease.

Authors:  John M Hwang; Madhulika G Varma
Journal:  World J Gastroenterol       Date:  2008-05-07       Impact factor: 5.742

Review 4.  Surgical strategies in paediatric inflammatory bowel disease.

Authors:  Colin T Baillie; Jennifer A Smith
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

5.  Primary sclerosing cholangitis and extraintestinal manifestations in patients with ulcerative colitis and ileal pouch-anal anastomosis.

Authors:  Hans H Wasmuth; Gerd Tranø; Birger H Endreseth; Arne Wibe; Astrid Rydning; Helge E Myrvold
Journal:  J Gastrointest Surg       Date:  2010-05-18       Impact factor: 3.452

6.  Clinical, serologic, and genetic factors associated with pyoderma gangrenosum and erythema nodosum in inflammatory bowel disease patients.

Authors:  Adam Weizman; Brian Huang; Dror Berel; Stephan R Targan; Marla Dubinsky; Phillip Fleshner; Andrew Ippoliti; Manreet Kaur; Deepa Panikkath; Steve Brant; Ioannis Oikonomou; Rick Duerr; John Rioux; Mark Silverberg; Jerome I Rotter; Eric Vasiliauskas; Talin Haritunians; David Shih; Dalin Li; Gil Y Melmed; Dermot P B McGovern
Journal:  Inflamm Bowel Dis       Date:  2014-03       Impact factor: 5.325

Review 7.  Autoinflammatory skin disorders in inflammatory bowel diseases, pyoderma gangrenosum and Sweet's syndrome: a comprehensive review and disease classification criteria.

Authors:  Angelo V Marzano; Rim S Ishak; Simone Saibeni; Carlo Crosti; Pier Luigi Meroni; Massimo Cugno
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

8.  Skin manifestations of inflammatory bowel disease.

Authors:  Brian L Huang; Stephanie Chandra; David Quan Shih
Journal:  Front Physiol       Date:  2012-02-06       Impact factor: 4.566

Review 9.  Management of cutaneous disorders related to inflammatory bowel disease.

Authors:  Zaira Pellicer; Jesus Manuel Santiago; Alejandro Rodriguez; Vicent Alonso; Rosario Antón; Marta Maia Bosca
Journal:  Ann Gastroenterol       Date:  2012

Review 10.  Ophthalmic manifestations in patients with inflammatory bowel disease: A review.

Authors:  Leandro Lopes Troncoso; Ana Luiza Biancardi; Haroldo Vieira de Moraes; Cyrla Zaltman
Journal:  World J Gastroenterol       Date:  2017-08-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.